Biceltis Trastuzumab Injection

Product Description

Biceltis Trastuzumab Injection contains the active ingredient trastuzumab, which is a monoclonal antibody used in the treatment of HER2-positive breast cancer and certain other HER2-positive cancers. It works by targeting and binding to the HER2 protein, which is overexpressed in HER2-positive cancers. This is typically administered intravenously (into a vein) under the supervision of a healthcare professional. By binding to HER2, trastuzumab inhibits the growth and proliferation of cancer cells and can also stimulate the immune system to attack cancer cells. Furthermore, you can avail the offer of Biceltis Trastuzumab Injection at very reasonable prices. 

Specification